Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution.
| Autor: | Nahmod KA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. 329-330. Date of Electronic Publication: 2023 May 27. |
| DOI: | 10.1002/ajh.26970 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text